Dynavax
Dynavax is a biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer.
Business Model:
Revenue: $733.3M
Employees: 201-500
Industries / Tags:
Detailed Dynavax Information
Geographic Data
Address: 2100 Powell Street
City: Emeryville
State: CA
Zip: 94608
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$200M
Raised Total:$563M
Social
Metrics
2,283,302Website Global Rank
8,301Website Monthly Traffic
Twitter Followers
Description
Dynavax is a biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer.
Contact Phone:
+15108485100
Contact Email:
Dynavax went public on 2/19/2004 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/19/2004
Ticker Symbol:
DVAX
IPO Price:
$7.5/share
Amount Raised:
$45M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2009 | Symphony Dynamo |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
